Related Experiment Videos
Determination of ifosfamide by HPLC using on-line sample preparation
C Zolezzi1, S Ferrari, G Bacci
1Laboratorio di Patologia Clinica, Istituti Ortopedici Rizzoli, Bologna, Italy.
Journal of Chemotherapy (Florence, Italy)
|March 17, 1999
Summary
A new HPLC method simplifies ifosfamide (IF) measurement using automated solid-phase extraction. This accurate technique aids in osteosarcoma treatment monitoring.
Area of Science:
- Analytical Chemistry
- Pharmacology
- Oncology
Background:
- Ifosfamide (IF) is a crucial chemotherapeutic agent, particularly for osteosarcoma.
- Accurate determination of IF levels is essential for effective treatment and patient monitoring.
- Existing methods for IF quantification can be complex and time-consuming.
Purpose of the Study:
- To develop and validate a novel, automated, and user-friendly High-Performance Liquid Chromatography (HPLC) method for ifosfamide determination.
- To assess the method's applicability in a clinical setting, specifically in osteosarcoma patients receiving IF therapy.
Main Methods:
- Development of an HPLC method incorporating on-line sample processing and automated solid-phase extraction.
- Integration of an automatic preparator with the chromatographic system for streamlined analysis.
- Validation of the method's linearity and sensitivity, establishing a calibration range and minimum detectable concentration.
Main Results:
- The developed HPLC method demonstrated linearity within the 6-200 microg/ml concentration range.
- A minimum detectable concentration of 6 microg/ml was achieved, indicating high sensitivity.
- The method proved to be highly accurate and easily reproducible, suitable for routine clinical use.
Conclusions:
- The novel automated HPLC method offers a reliable and efficient approach for ifosfamide quantification.
- This method facilitates precise monitoring of ifosfamide levels during osteosarcoma treatment with slow infusion protocols.
- The ease of application and high accuracy make this method valuable for clinical laboratories and oncologists.